Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole +/- Fulvestrant as First-Line Therapy for Metastatic Breast Cancer
NCT00075764Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2004
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of fulvestrant in breast cancer, sponsored by SWOG Cancer Research Network. Started Apr 2004; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00075764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075764.